Based on the results of the immunoblotting experiments, treatment with Orp not only reduced the expression of full-length PARP (implying that Orp promoted the cleavage of the apoptotic protein PARP) in tumor tissues but also inhibited the protein expression of PCNA (Figure S2B). This evidence concerns the gene PCNA and neoplasm.